Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio (Newsfile Corp)

Cosmo Pharmaceuticals has appointed Andrea Cherubini as its first Chief AI Officer, signaling a major shift toward AI-driven innovation across its portfolio. Cherubini, who played a key role in the development of GI Genius™, the world’s first AI-powered polyp detection system, will now expand AI applications in gastroenterology, dermatology, and drug discovery. His leadership aims to enhance precision medicine, optimize clinical trials, and accelerate AI-enabled drug development. Cosmo’s CEO emphasized that AI is now a core pillar of the company’s growth strategy, with plans to drive innovation beyond endoscopy.